Tablets, Capsules, APIs
Total Trials
31
As Lead Sponsor
As Collaborator
0
Total Enrollment
15,464
NCT01554930
Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2010
Completion: Dec 31, 2011
NCT02937857
An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.
Phase: Phase 4
Start: Aug 31, 2016
Completion: Aug 31, 2020
NCT02940132
A Study of SC10914 in Patients With Advanced Solid Tumors
Phase: Phase 1
Start: Oct 31, 2016
Completion: May 31, 2018
NCT03132610
A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis
Start: Dec 1, 2016
Completion: Jun 1, 2018
NCT03132623
Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis
NCT03134443
Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis
NCT03358485
Study of Aolanti Weikang Tablets in Healthy Volunteers
Start: Dec 14, 2017
Completion: Jun 30, 2018
NCT03641794
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
Start: Sep 7, 2018
Completion: Jul 31, 2019
NCT03947411
Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
Start: Mar 4, 2019
Completion: Mar 31, 2020
NCT03971383
Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
Phase: Phase 2
Start: Jun 10, 2019
Completion: May 3, 2021
NCT04158310
Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children
Start: Nov 11, 2019
Completion: Mar 1, 2021
NCT04295551
Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
Start: Mar 14, 2020
Completion: Apr 14, 2021
NCT04275388
Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
Start: May 15, 2020
Completion: Dec 14, 2021
NCT04296383
Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia
Start: Jun 15, 2020
Completion: Aug 15, 2022
NCT04556292
A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients
Start: Aug 12, 2020
Completion: Aug 30, 2022
NCT04729764
Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects
Start: Aug 27, 2020
Completion: Dec 15, 2020
NCT04486937
SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation
Phase: Phase 1/2
Start: Aug 30, 2020
Completion: Jun 30, 2022
NCT04556539
Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer
Start: Dec 15, 2020
Completion: Dec 31, 2022
NCT04736758
A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza
Start: Jan 8, 2021
Completion: Dec 18, 2021
NCT04737837
A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy
Start: Jan 31, 2021
Completion: Feb 28, 2022
NCT04891653
A Phase I Study of BR790 in Subjects With Advanced Solid Tumors
Start: Jun 30, 2021
Completion: Dec 31, 2023
NCT04926506
Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children
Start: Oct 8, 2021
Completion: Dec 30, 2022
NCT05103241
A Phase I Mass Balance Study of [14C]GP681 in Healthy Chinese Male Volunteers
Start: Oct 26, 2021
Completion: Nov 22, 2021
NCT05474755
To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection
Phase: Phase 3
Start: Jul 28, 2022
Completion: Oct 31, 2023
NCT05789342
A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers
Start: Feb 15, 2023
NCT05814926
GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers
Start: Apr 26, 2023
Completion: Oct 20, 2023
NCT06643156
Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension
Start: Sep 27, 2024
Completion: Jan 18, 2025
NCT06678542
Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects
Completion: Feb 16, 2025
NCT06573008
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
Start: Nov 11, 2024
Completion: Dec 30, 2025
NCT06574503
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
Start: Dec 1, 2024
Completion: Dec 30, 2027
NCT06754865
Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data
Start: Dec 31, 2024
Completion: Nov 30, 2025
Loading map...